Skip to main content
Empower Clinics Inc. logo

Empower Clinics Inc. — Investor Relations & Filings

Ticker · EPW ISIN · CA29246V2030 LEI · 5299003VJ8DEUQLLRJ76 CSE Human health and social work activities
Open in API
Filings indexed 224 across all filing types
Latest filing 2025-05-21 Regulatory Filings
Country CA Canada
Listing CSE EPW

About Empower Clinics Inc.

www.empowerclinics.com

Empower Clinics Inc. is an integrated healthcare and medical device company dedicated to providing comprehensive body and mind wellness services. The company delivers patient-centric care through a network of multi-disciplinary medical clinics, including locations operating under "The Medi-Collective" (TMC) brand, which offer primary care and walk-in services. Care delivery utilizes physical clinics, digital health technology platforms, and telemedicine solutions. Empower Clinics also develops health technology platforms designed to help patients efficiently find the care they require.

Recent filings

Filing Released Lang Actions
Report of exempt distribution (45-106F1).pdf
Regulatory Filings Classification · 87% confidence The document is a Canadian securities regulatory Form 45-106F1 “Report of Exempt Distribution,” containing the issuer’s detailed disclosure of an exempt securities distribution (dates, amounts, purchaser schedules, compensation, etc.) as required under NI 45-106. It is a statutory regulatory filing that does not fit any of the other more specific categories (e.g., earnings release, proxy, share issue announcement, etc.), so it falls into the general “Regulatory Filings” fallback category.
2025-05-21 English
Material change report - English.pdf
Board/Management Information Classification · 95% confidence The document is titled 'Material Change Report' and details the resignation of two directors effective immediately. It includes company name, date of material change, a news release summary, and a full description of the material change. The content focuses on changes in the company's board of directors, specifically resignations, which aligns with announcements about changes in senior management or board members. There is no financial data, earnings information, or report publication mentioned. The document is not a full annual report, audit report, or earnings release. It is not a proxy solicitation or voting results announcement. Therefore, the document fits best under the category of Board/Management Information (MANG). The document length is about 4825 characters, sufficient to be a full announcement rather than a brief notice or report publication announcement. Confidence is high due to clear focus on director resignations and management changes.
2024-07-04 English
Material change report - English.pdf
Regulatory Filings Classification · 95% confidence The document is titled 'Material Change Report' and details a material change involving a partial revocation of a cease trade order by securities commissions, allowing the company to proceed with a private placement and a shares for debt transaction. It includes detailed disclosure required by Multilateral Instrument 61-101, which governs protection of minority security holders in special transactions. The document focuses on the description of the transaction, related party interests, board approval, and regulatory compliance. There are no financial statements or comprehensive financial data presented, nor is this an earnings release or annual/interim report. The document is a regulatory filing notifying the market and regulators of a material corporate event and related transactions. This fits the definition of a Regulatory Filing (RNS) as it is a general regulatory announcement and does not fit other more specific categories such as Capital/Financing Update (CAP) because it is primarily a regulatory disclosure rather than a financing update announcement. The document length and detail confirm it is not a brief announcement but a formal regulatory filing.
2024-04-03 English
News release - English.pdf
Capital/Financing Update Classification · 95% confidence The document is a press release announcing the issuance of a Partial Revocation Order by the British Columbia Securities Commission related to a cease trade order due to failure to file annual audited financial statements and other filings. It details the company's plans to complete a private placement and a shares for debt transaction, including related party transaction disclosures and regulatory compliance notes. The document does not contain actual financial statements or detailed financial performance data but rather focuses on regulatory updates and financing activities. Therefore, it is best classified as a Capital/Financing Update (CAP). The document length (6769 characters) and content confirm it is not merely an announcement of a report but a substantive update on financing and regulatory status.
2024-04-03 English
News release - English.pdf
Capital/Financing Update Classification · 95% confidence The document is a press release announcing a multi-year clinical trial contract with a top 10 global pharmaceutical company. It details the contract terms, patient recruitment plans, and the company's strategic pivot into pharmaceutical clinical trials. There are no financial statements, regulatory certifications, voting results, or management changes. The content focuses on a business development update related to clinical trial contracts and revenue generation from these activities. This fits best under Capital/Financing Update (CAP) as it relates to new revenue streams and contract announcements impacting the company's capital and business operations. The document length is sufficient and contains substantive information about the contract and its financial implications, not merely an announcement of a report or a regulatory filing. Therefore, the classification is CAP with high confidence.
2023-12-05 English
News release - English.pdf
Capital/Financing Update Classification · 95% confidence The document is a corporate update from Empower Clinics, discussing a Cease Trade Order issued by the British Columbia Securities Commission due to the company being late in filing its adjusted year-end financials. It mentions audit procedures, a debt settlement agreement involving issuance of shares, and operational updates including bankruptcy of a subsidiary. The document does not contain full financial statements or detailed financial performance data but rather provides regulatory and corporate status updates, including audit status and capital structure changes (debt settlement via share issuance). It is not a full annual or interim report, nor an earnings release. The focus on audit status and regulatory halt due to late filing, plus the debt settlement share issuance, aligns best with a Capital/Financing Update (CAP). The document is over 6,000 characters and contains substantive information, not just an announcement of a report or certification. Therefore, the classification is Capital/Financing Update (CAP).
2023-08-19 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.